ArticleCancer research communications2025

Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma.

Jan F Hollander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.